# Acamprosate Treatment: Mechanisms of Action

> **NCT00004552** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 120 (—)

## Conditions studied

- Alcoholism

## Interventions

- **DRUG:** acamprosate (Campral)

## Key facts

- **NCT ID:** NCT00004552
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2002-12
- **Target enrollment:** 120 (—)
- **Last updated:** 2015-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004552, "Acamprosate Treatment: Mechanisms of Action". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00004552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*